Biotechnology Fund Financials

Biotechnology Fund Fund Summary

Biotechnology Fund competes with Technology Fund, Perkins Select, Eventide Exponential, Electronics Fund, and Perkins Select. Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Biotechnology Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Fund's current stock value. Our valuation model uses many indicators to compare Biotechnology Fund value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Fund competition to find correlations between indicators driving Biotechnology Fund's intrinsic value. More Info.Biotechnology Fund Investor is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about  0.19  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Biotechnology Fund Investor is roughly  5.28 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Fund's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Biotechnology Fund help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biotechnology Fund Investor. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biotechnology Fund Investor based on widely used predictive technical indicators. In general, we focus on analyzing Biotechnology Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biotechnology Fund's daily price indicators and compare them against related drivers.

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.